Skip to main content
    P

    Pulmatrix Inc (PULM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.29
    -0.01 (-0.76%)

    Market Cap: $4.71M

    Last updated: Nov 17, 2026 at 10:46 AM ET

    Pulmatrix Inc (PULM) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Pulmatrix are Processa Pharmaceuticals (PCSA), Liminatus Pharma, Inc. Class A Common Stock (LIMN) and Aprea Therapeutics (APRE). By market cap, Pulmatrix ranks 9th of the 13 companies on this page; Phio Pharmaceuticals (PHIO) is the largest at $9.21M.

    Peer Comparison

    PULM's revenue growth of -99.9% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Pulmatrix (PULM)$4.71MN/AN/A0.0%N/A-99.9%0.00%
    Processa Pharmaceuticals Inc (PCSA)$5.20MN/AN/A0.0%N/A0.0%0.00%
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)$4.02MN/AN/A0.0%-247.2%0.0%0.00%
    Aprea Therapeutics Inc (APRE)$5.91MN/AN/A0.0%N/A-98.4%0.00%
    Moleculin Biotech Inc (MBRX)$8.02MN/AN/A0.0%N/A0.0%0.00%
    Galmed Pharmaceuticals Ltd (GLMD)$4.95MN/AN/A0.0%N/A0.0%N/A
    Traws Pharma Inc (TRAW)$3.86MN/AN/A0.0%N/A-100.0%0.00%
    Soligenix Inc. (SNGX)$7.50MN/AN/A0.0%N/A-100.0%0.00%
    Mustang Bio Inc (MBIO)$3.20MN/AN/A0.0%N/A0.0%0.00%
    Phio Pharmaceuticals Corp (PHIO)$9.21MN/AN/A0.0%N/A0.0%0.00%
    Immuron Ltd ADR (IMRN)$7.06MN/A0.9x-47.7%N/A7.2%0.00%
    Purple Biotech (PPBT)$2.65MN/AN/A0.0%-156.2%0.0%0.00%
    Lantern Pharma Inc (LTRN)$6.47MN/AN/A0.0%N/A0.0%0.00%
    Peer median$5.56MN/A0.9x0.0%-201.7%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Pulmatrix, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Processa Pharmaceuticals Inc (PCSA)
    Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients...
    PCSA competitors
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)
    Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California.
    LIMN competitors
    Aprea Therapeutics Inc (APRE)
    Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies that reactivate the mutant p53 tumor suppressor...
    APRE competitors
    Moleculin Biotech Inc (MBRX)
    Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of cancer drug candidates for the treatment of highly resistant...
    MBRX competitors
    Galmed Pharmaceuticals Ltd (GLMD)
    Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment of liver diseases.
    Traws Pharma Inc (TRAW)
    Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States.
    TRAW competitors
    Soligenix Inc. (SNGX)
    Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States.
    SNGX competitors
    Mustang Bio Inc (MBIO)
    Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures...
    MBIO competitors
    Phio Pharmaceuticals Corp (PHIO)
    Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts.
    PHIO competitors
    Immuron Ltd ADR (IMRN)
    Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious...
    Purple Biotech (PPBT)
    Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United...
    PPBT competitors
    Lantern Pharma Inc (LTRN)
    Lantern Pharma Inc., a clinical-stage biotechnology company, focuses on developing precision cancer therapies using artificial intelligence, genomics...
    LTRN competitors

    Frequently Asked Questions About PULM

    Who are Pulmatrix's main competitors?

    The companies most similar to Pulmatrix include Processa Pharmaceuticals (PCSA), Liminatus Pharma, Inc. Class A Common Stock (LIMN), Aprea Therapeutics (APRE), Moleculin Biotech (MBRX) and Galmed Pharmaceuticals (GLMD), listed from the closest match.

    Who is Pulmatrix's biggest competitor?

    Phio Pharmaceuticals (PHIO) is the largest of the similar companies at $9.21M; Processa Pharmaceuticals (PCSA) is the closest match by business profile, size, sector and industry.

    How does PULM stock compare with its competitors?

    PULM's net margin is 0.0% against a peer median of 0.0%.

    Which of Pulmatrix's competitors pays a higher dividend?

    Pulmatrix pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Pulmatrix bigger than its competitors?

    No. Pulmatrix is 9th by market cap among the 13 companies on this page; the largest is Phio Pharmaceuticals (PHIO) at $9.21M.